Blackstone Group Lp Company Profile

Aggregated data from the web about Blackstone Group Lp

Company Name	Blackstone Group Lp
Website	https://www.blackstone.com
Snippet	Blackstone (NYSE: BX) and Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata”), a clinical-stage biopharmaceutical company, today announced that funds managed by Blackstone Life Sciences (“BXLS”) will lead a $350 million royalty and equity investment in Reata to fund the development and potential commercialization of bardoxolone methyl (“bardoxolone”), an investigational once-daily ...
AUM	US$571 billion[1]
ISIN	US09253U1088
Type	Public
Founded	1985
Founder	Peter G. PetersonStephen A. Schwarzman
Revenue	US$7.119 billion (2017)
Website	www.blackstone.com
Industry	Financial services
Products	Private equityalternative investment management
Traded as	NYSE: BX
Key people	Stephen A. Schwarzman, chairman and CEO, Jonathan D. Gray, president and COO, Hamilton E. James, executive vice chairman, Byron Wien, vice chairman of Blackstone Advisory Partners
Net income	US$1.471 billion (2017)
Headquarters	345 Park AvenueNew York, NY 10154US
Subsidiaries	Hilton WorldwideMerlin Entertainments GroupEuro Garages[citation needed]
Total assets	US$34.429 billion (2017)
Operating income	US$4.117 billion (2017)
Number of employees	2,360[2] (2017)

Blackstone Group Lp is part of the United States company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.